Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 17, 2022
Reporting Period: The filing announces the issuance of a press release containing sales and operating results for the three-month and twelve-month periods ended December 31, 2021.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue/Profit: Not provided in this text; referenced in attached press release.
- Cash Flow/Liquidity: Not provided in this text.
- Debt: Not provided in this text.
Material Changes
The filing does not detail specific material changes or comparative figures versus prior periods. It solely confirms the public disclosure of results for the periods ended December 31, 2021.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the release of a press report on February 17, 2022, regarding operational results.
Guidance/Risks: No specific guidance, outlook, risk factors, or contingencies are detailed within the body of this 8-K text. The information is deemed "furnished" rather than "filed" under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 17, 2022) for actual revenue, net income, and EPS figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking statements or updated guidance included in the press release.
- Confirm the status of the company as an emerging growth company (indicated as checked in the filing).